Home » Topics » BioWorld Science

BioWorld Science
RSS

Sonnet selects SON-1410 as development candidate for melanoma and renal cancers

Aug. 31, 2021

Satellos determines high-resolution crystal structure of target for Duchenne muscular dystrophy

Aug. 31, 2021

Genexine divulges new anti-PD-L1 fusion proteins

Aug. 31, 2021

Preclinical data highlight CAN-04 mode of action in potentiating efficacy of docetaxel

Aug. 31, 2021

Investigators identify new gene mutations behind hereditary optic neuropathy

Aug. 31, 2021

New class of Mcl-1 inhibitors developed at Janssen for treating myeloma

Aug. 31, 2021

Low-dose targeted radionuclide therapy using [90Y]NM-600 promotes response to ICIs

Aug. 31, 2021

New heart failure animal model also captures arrhythmia susceptibility

Aug. 31, 2021

Scientists discover and characterize a selective hCYP11B2 PET tracer for primary hyperaldosteronism

Aug. 31, 2021

New benzimidazole derivative as a selective RORgamma inverse agonist for prostate cancer treatment

Aug. 31, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...